Research Article

Open Access
A systems-based method to repurpose marketed therapeutics for antiviral use: a SARS-CoV-2 case study
Mengran Wang, Johanna B Withers, Piero Ricchiuto, Ivan Voitalov, Michael McAnally, Helia N Sanchez, Alif Saleh, Viatcheslav R Akmaev, View ORCID ProfileSusan Dina Ghiassian Correspondence email
Mengran Wang
Scipher Medicine Corporation, Waltham, MA, USA
Johanna B Withers
Scipher Medicine Corporation, Waltham, MA, USA
Piero Ricchiuto
Scipher Medicine Corporation, Waltham, MA, USA
Ivan Voitalov
Scipher Medicine Corporation, Waltham, MA, USA
Michael McAnally
Scipher Medicine Corporation, Waltham, MA, USA
Helia N Sanchez
Scipher Medicine Corporation, Waltham, MA, USA
Alif Saleh
Scipher Medicine Corporation, Waltham, MA, USA
Viatcheslav R Akmaev
Scipher Medicine Corporation, Waltham, MA, USA
Susan Dina Ghiassian
Scipher Medicine Corporation, Waltham, MA, USA
Published 16 February 2021. DOI: 10.26508/lsa.202000904
Systems-based antiviral identification
Mengran Wang, Johanna B Withers, Piero Ricchiuto, Ivan Voitalov, Michael McAnally, Helia N Sanchez, Alif Saleh, Viatcheslav R Akmaev, Susan Dina Ghiassian
Life Science Alliance Feb 2021, 4 (5) e202000904; DOI: 10.26508/lsa.202000904
In this Issue
Volume 4, No. 5
May 2021
Advertisement